MedTrace Logo

A Prospective Outcome Study in Patients With Moderate to Severe Traumatic Brain Injury

NCT03810222 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2021-02-24

No results posted yet for this study

Summary

Traumatic brain injury (TBI) is the leading cause of death, disability and cognitive impairment in young people worldwide. The majority of the traumatic deaths in developed countries results directly from lesions in the central nervous system. Furthermore, due to the persistence of disabling effects of TBI for many years, personal and public costs of supporting survivors have to be taken in consideration.

Many patients rescued by ICU treatment may have been severely disabled or vegetative because of trauma. These data suggest that, despite improvement in medical and surgical treatments, other factors related to trauma itself and to patient's condition could have an impact on the final outcome.

Aim of the TBI-PRO project is to collect high quality clinical and epidemiological data and to describe the outcome of moderate-to-severe TBI in a local contest (Bergamo area, Italy).

Conditions

  • Brain Injuries, Traumatic
  • Brain Injury Traumatic Moderate
  • Brain Injury Traumatic Severe

Interventions

OTHER

N/A (Observational Study)

This is an observational study and does not include interventions. Exposure is TBI.

Sponsors & Collaborators

  • FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

    lead OTHER

Principal Investigators

  • PAOLO GRITTI, MD · ASST- Papa Giovanni XXIII

  • FRANCESCO BIROLI, MD · Fondazione per la Ricerca Ospedale di Bergamo (FROM)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-18
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03810222 on ClinicalTrials.gov